Puskás László and Mán Imola and Szebeni Gábor and Tiszlavicz László and Tsai Susan and James Michael A.:
Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.
MOLECULAR CANCER THERAPEUTICS, 15 (5).
pp. 985-997.
ISSN 1535-7163
(2016)
![]() |
Text
MCT_Tiszlavicz_2016_u.pdf - Published Version Restricted access: Logged in users only Download (3MB) | Request a copy |
Item Type: | Journal Article |
---|---|
Journal or Publication Title: | MOLECULAR CANCER THERAPEUTICS |
Date: | 2016 |
Volume: | 15 |
Number: | 5 |
Page Range: | pp. 985-997 |
ISSN: | 1535-7163 |
Faculty/Unit: | Faculty of Medicine |
Institution: | Szegedi Tudományegyetem |
Language: | English |
MTMT rekordazonosító: | 3032869 |
DOI azonosító: | https://doi.org/10.1158/1535-7163.MCT-15-0717 |
Date Deposited: | 2017. Jul. 27. 14:37 |
Last Modified: | 2019. Dec. 05. 16:32 |
URI: | http://publicatio.bibl.u-szeged.hu/id/eprint/11815 |
Web of Science® Times Cited: 11 | View citing articles in Web of Science® |
Actions (login required)
![]() |
View Item |